Innovation

Who are today’s leading global innovators?

Clarivate Analytics has again recognized the most innovative organizations worldwide for the seventh consecutive year with the publication today of the “2017 Top 100 Global Innovators” report.  This seeks to address the question of who today’s leading global innovators are, and to celebrate their achievements and contributions to enriching the world through innovation. The ranking […]

For the tradition-bound biopharma industry, resisting change is no longer an option

“For nearly half a century the pharmaceutical industry has lagged other industries in terms of productivity, efficiency and, some might argue, innovation,” wrote Bikash Chatterjee. “The excuse was that, as a regulated industry, any flexibility to implement improvements is limited, and compliance is of paramount importance.” Chatterjee, president and CSO of Pharmatech Associates, made these […]

Recent Advances & Trends – South Africa’s Top 5 Innovative Universities

What are the recent advances and trends in the scientific research and innovation outputs of South African universities? We have taken a retrospective look at the Top 5 Innovative Universities in South Africa, examining what these institutions are doing in relation to collaborative and industry partners and their conversion of science into innovation. North-West University […]

R&D spend up, capital down makes for shorter runways for midmarket biotech companies

Spending on R&D by midmarket biotech companies increased 18 percent from 2015 to 2016, from an average of $65.9 million to an average of $80.6 million, according to the 2017 BDO Biotech Briefing, a report from BDO USA LLP analyzing the 10-K SEC filings from companies in the Nasdaq Biotechnology Index (NBI) with revenue of less than $300 million.

Innovation comes with hefty price tag as biopharma R&D spend climbs

To keep biopharmaceutical innovation churning requires mountains of cash. Companies will need to invest as much as $2.5 billion over a 10- to 15-year period in order to bring a new therapy to the marketplace, according to a 2014 study conducted by the Tufts Center for the Study of Drug Development.

Powering the world’s leading research and assessment organizations

In evaluating research, it is critical to work with the most comprehensive global data and the most insightful analytics. Indeed, as the global academic landscape continues to expand, it is more important than ever to assess performance and recognize the accomplishments of the top universities.